At I/O 2025, Google Vice President and General Manager of Ads and Commerce Vidhya Srinivasan—a role that also oversees ...

Algorithms have been used in trading for decades, but recent advancements could throw up new challenges for regulators. View ...

Astro Bot is a game with a high degree of polish, with very little in the way of bugs or glitches — but that doesn't stop speedrunners from cracking it open. IGN recently posted a new episode in ...

The underlying methodology defining Perplexity WhatsApp bot is the same as Perplexity’s AI app or the interface on the web — access to multiple models 500 million users and counting ...

OpenAI on Tuesday rolled back its latest ChatGPT update for being too “sycophantic” after the chatbot gave oddly supportive, touchy-feely responses to users who made bizarre claims about ...

Throw artificial intelligence into the mix, and it gets worse. Old-school bot detection techniques like CAPTCHAs— where users are asked to select squares that contain a motorcycle or decipher a ...

Academics from the University of Zurich (UZH) have confirmed they deployed AI-driven accounts to secretly post comments within Reddit’s r/changemyview (CMV) community. The unauthorized ...

Since September 2024, Microsoft has been letting interested admins try out hot patching for Windows Server 2025 free of charge. This allows security updates to be applied without the need to ...

The Bank of Thailand (BoT) is widely expected to trim its key policy rate by 0.25 percentage points tomorrow, April 30, as the kingdom battles a growing storm of economic setbacks. Kasikorn Research ...

The Open AI CEO says that GPT-4o’s sycophantic tendencies will be dialed back. The Open AI CEO says that GPT-4o’s sycophantic tendencies will be dialed back. Gaby Del Valle is a policy ...

Initial results from NEOASIS demonstrate BOT/BAL efficacy in the neoadjuvant setting across multiple MSS and MSI-H solid tumors LEXINGTON, Mass., April 28, 2025--(BUSINESS WIRE)--Agenus Inc ...

This represents the third clinical study evaluating botensilimab and balstilimab (BOT/BAL) in the neoadjuvant setting, with outcomes reported in mismatch repair–proficient (pMMR/MSS) and ...